# Precision Medicine
Latest news and articles about Precision Medicine
Total: 3 articles found
Chasing the Holy Grail: HEC Pharm’s Triple Threat at AACR 2026 Signals China’s Oncology Pivot
HEC Pharm presented three innovative oncology candidates at the 2026 AACR meeting, showcasing breakthroughs in Pan-RAS molecular glues, bispecific antibodies, and oral PD-L1 inhibitors. This move highlights the company's strategic pivot toward high-complexity R&D and its ambition to compete in the global precision medicine market.
Salubris Biotherapeutics Unveils Promising Clinical Data for Novel ADC, Signaling China’s Global Precision Oncology Push
Salubris Biotherapeutics has reported positive Phase 1/2 clinical data for its 5T4-targeting ADC, JK06, at the AACR 2026 conference. The drug shows promising safety and efficacy in treating advanced lung and breast cancers, marking a key advancement in the company's international clinical pipeline.
Precision Oncology Gains Ground in China: AmoyDx Secures Regulatory Nod for c-Met Lung Cancer Diagnostic
Amoy Diagnostics has received NMPA approval for its c-Met gene amplification kit, a companion diagnostic for the lung cancer drug Savolitinib. This development marks a vital step in China's push for localized precision oncology and sophisticated personalized medicine tools.